GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Trastuzumab|DRUG: GDC-0084
Sponsor: Dana-Farber Cancer Institute
Collaborators: Kazia Therapeutics Limited